Harvard Apparatus Regenerative Technology

(OTC) HRGN

Current Price$1.31

Market Cap$24.61M

Since IPO (2013)-99%

5 Year+6%

1 Year-15%

1 Month-17%

Harvard Apparatus Regenerative Technology Financials at a Glance

Market Cap

$24.61M

Revenue (TTM)

$445.00K

Net Income (TTM)

-$6.81M

EPS (TTM)

-$0.40

P/E Ratio

-3.47

Dividend

$0.00

Beta (Volatility)

-0.19 (Low)

Dividend

$0.00

Beta (Volatility)

-0.19 (Low)

Price

$1.31

Volume

200

Open

$1.40

Price

$1.31

Volume

200

Open

$1.40

Previous Close

$1.40

Daily Range

$1.31 - $1.40

52-Week Range

$0.94 - $2.22

Dividend

$0.00

Beta (Volatility)

-0.19 (Low)

Price

$1.31

Volume

200

Open

$1.40

Previous Close

$1.40

Daily Range

$1.31 - $1.40

52-Week Range

$0.94 - $2.22

HRGN News

I'm Selling Harvard Apparatus Regenerative Technology

Jim RoyalNov 18, 2014

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Harvard Apparatus Regenerative Technology

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jun Li He, CFA, MBA

Website

hregen.com

Headquarters

Holliston, MA 01746, US

HRGN Financials

Key Financial Metrics (TTM)

Gross Margin

-84%

Operating Margin

-17%

Net Income Margin

-15%

Return on Equity

-637%

Return on Capital

-51%

Return on Assets

-4%

Earnings Yield

-28.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$24.61M

Shares Outstanding

17.58M

Volume

200

Avg. Volume

555.23

Financials (TTM)

Gross Profit

$58.00K

Operating Income

-$7.62M

EBITDA

-$6.76M

Operating Cash Flow

-$3.83M

Capital Expenditure

$0.00

Free Cash Flow

-$3.83M

Cash & ST Invst.

$1.35M

Total Debt

$199.00K

Harvard Apparatus Regenerative Technology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$226.00K

N/A

Gross Profit

$20.00K

+160.6%

Gross Margin

8.85%

N/A

Market Cap

$24.61M

N/A

Market Cap/Employee

$3.08M

N/A

Employees

N/A

Net Income

-$1.60M

+3.5%

EBITDA

-$1.57M

+8.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$246.00K

-83.1%

Accounts Receivable

$16.00K

+300.0%

Inventory

$15.00K

-68.8%

Long Term Debt

$55.00K

-68.0%

Short Term Debt

$118.00K

+18.0%

Return on Assets

-3.79%

N/A

Return on Invested Capital

-51.14%

N/A

Free Cash Flow

-$937.00K

-23.6%

Operating Cash Flow

-$937.00K

-23.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MVRBFMedivir AB (publ)

MVRBFMedivir AB (publ)$0.82+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ASTCAstrotech

ASTCAstrotech$10.03+3.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.41+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$80.68-0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.86+0.01%

APPSDigital Turbine

APPSDigital Turbine$7.42+0.54%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.04+0.01%

NVDANvidia

NVDANvidia$209.14-0.03%

Questions About HRGN

What is the current price of Harvard Apparatus Regenerative Technology?

Harvard Apparatus Regenerative Technology is trading at $1.31 per share.

What is the 52-week range for Harvard Apparatus Regenerative Technology?

Over the past 52 weeks, Harvard Apparatus Regenerative Technology has traded between $0.94 and $2.22.

How much debt does Harvard Apparatus Regenerative Technology have?

As of the most recent reporting period, Harvard Apparatus Regenerative Technology reported total debt of $288.00K.

How much cash does Harvard Apparatus Regenerative Technology have on hand?

Harvard Apparatus Regenerative Technology reported $419.00K in cash and cash equivalents in its most recent financial results.

What is Harvard Apparatus Regenerative Technology’s dividend yield?

Harvard Apparatus Regenerative Technology does not currently have a dividend yield.

Harvard Apparatus Regenerative Technology

Harvard Apparatus Regenerative Technology Financials at a Glance

HRGN News

I'm Selling Harvard Apparatus Regenerative Technology

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Harvard Apparatus Regenerative Technology

HRGN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Harvard Apparatus Regenerative Technology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HRGN

What is the current price of Harvard Apparatus Regenerative Technology?

What is the 52-week range for Harvard Apparatus Regenerative Technology?

How much debt does Harvard Apparatus Regenerative Technology have?

How much cash does Harvard Apparatus Regenerative Technology have on hand?

What is Harvard Apparatus Regenerative Technology’s dividend yield?

Premium Investing Services